Tuberculosis in patients with human immunodeficiency virus infection

New England Journal of Medicine

Volumn 324, Issue 23, 1991, Pages 1644-1650

  Desforges, Jane F ^a   Barnes, Peter F ^a   Davidson, Paul T ^b   Bloch, Alan B ^c   Snider, Dixie E ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Los Angeles County Department of Public Health   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRONCHOSCOPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS; VIRUS TRANSMISSION; LUNG TUBERCULOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; HIV INFECTIONS; HUMAN; SUPPORT, U.S. GOV'T, P.H.S.; TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 0025737457     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199106063242307     Document Type: Review

References (60)

1. Rieder HL, Cauthen GM, Kelly GD, Bloch AB, Snider DE Jr. Tuberculosis in the United States. JAMA 1989; 262:385–9.
2. Rieder HL, Cauthen GM, Comstock GW, Snider DE Jr. Epidemiology of tuberculosis in the United States. Epidemiol Rev 1989; 11:79–98.
3. Update: tuberculosis elimination — United States. MMWR 1990; 39:153–6.
4. Cases of specified notifiable diseases, United States, weeks ending December 29, 1990, and December 30, 1989 (52nd week). MMWR 1991; 39: 944.
5. Bender BS, Davidson BL, Kline R, Brown C, Quinn TC. Role of the mononuclear phagocyte system in the immunopathogenesis of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Rev Infect Dis 1988; 10:1142–54.
6. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320:545–50.
7. Di Perri G, Cruciani M, Danzi MC, et al. Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet 1989; 2:1502–4.
8. Tuberculosis — United States, 1985. MMWR 1986; 35:699–703.
9. Tuberculosis — United States, 1985 — and the possible impact of the human lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR 1986; 35:74–6.
10. Tuberculosis and acquired immunodeficiency syndrome — New York City. MMWR 1987; 36:785–90, 795.
11. Pitchenik AE, Fertel D, Bloch AB. Mycobacterial disease: epidemiology, diagnosis, treatment, and prevention. Clin Chest Med 1988; 9:425–41.
12. Bloch AB, Rieder HL, Kelly GD, Cauthen GM, Hayden CH, Snider DE. The epidemiology of tuberculosis in the United States. Semin Respir Infect 1989; 4: 157—70.
13. Pitchenik AE, Cole C, Russell BW, Fischl MA, Spira TJ, Snider DE. Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida. Ann Intern Med 1984; 101:641–5.
14. Rieder HL, Cauthen GM, Bloch AB, et al. Tuberculosis and acquired immunodeficiency syndrome — Florida. Arch Intern Med 1989; 149:1268–73.
15. Sunderam G, McDonald RJ, Maniatis T, Oleske J, Kapila R, Reichman LB. Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS). JAMA 1986; 256:362–6.
16. Chaisson RE, Schecter GF, Theuer CP, Rutherford GW, Echenberg DF, Hopewell PC. Tuberculosis in patients with the acquired immunodeficiency syndrome: clinical features, response to therapy, and survival. Am Rev Respir Dis 1987; 136:570–4.
17. Rieder HL, Snider DE Jr. Tuberculosis and the acquired immunodeficiency syndrome. Chest 1986; 90:469–70.
18. Estimates of HIV prevalence and projected AIDS cases: summary of a workshop, October 31—November 1, 1989. MMWR 1990; 39:110–9.
19. McCray E, Onorato IM, Miller BI, Dondero TJ Jr, Bloch AB. Estimating HIV levels and trends among patients of tuberculosis clinics. Public Health Rep 1990; 105:135–40.
20. Centers for Disease Control. National HIV seroprevalence surveys: summary of results: data from serosurveillance activities through 1989. Washington, D.C.: Government Printing Office, 1990. (DHHS publication no. HIV/CID/9–90/006.)
21. Pitchenik AE, Burr J, Suarez M, Fertel D, Gonzalez G, Moas C. Human T-cell lymphotropic virus-III (HTLV-III) seropositivity and related disease among 71 consecutive patients in whom tuberculosis was diagnosed: a prospective study. Am Rev Respir Dis 1987; 135:875–9.
22. Modilevsky T, Sattler FR, Barnes PF. Mycobacterial disease in patients with human immunodeficiency virus infection. Arch Intern Med 1989; 149:2201–5.
23. Theuer CP, Hopewell PC, Elias D, Schecter GF, Rutherford GW, Chaisson RE. Human immunodeficiency virus infection in tuberculosis patients. J Infect Dis 1990; 162:8–12.
24. Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). MMWR 1989; 38: 236–8, 243–50.
25. Handwerger S, Mildvan D, Senie R, McKinley FW. Tuberculosis and the acquired immunodeficiency syndrome at a New York City hospital: 1978–1985. Chest 1987; 91:176–80.
26. Louie E, Rice LB, Hoizman RS. Tuberculosis in non-Haitian patients with acquired immunodeficiency syndrome. Chest 1986; 90:542–5.
27. Kramer F, Modilevsky T, Waliany AR, Leedom JM, Barnes PF. Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Am J Med 1990; 89:451–6.
28. Shafer RW, Goldberg R, Sierra M, Glatt AE. Frequency of Mycobacterium tuberculosis bacteremia in patients with tuberculosis in an area endemic for AIDS. Am Rev Respir Dis 1989; 140:1611–3.
29. Colebunders RL, Ryder RW, Nzilambi N, et al. HIV infection in patients with tuberculosis in Kinshasa, Zaire. Am Rev Respir Dis 1989; 139:1082–5.
30. Pitchenik AE, Rubinson HA. The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS. Am Rev Respir Dis 1985; 131:393–6.
31. Meduri GU, Stover DE, Lee M, Myskowski PL, Caravelli JF, Zaman MB. Pulmonary Kaposi's sarcoma in the acquired immune deficiency syndrome: clinical, radiographic, and pathologic manifestations. Am J Med 1986; 81:11–8.
32. O'Brien RF, Cohn DL. Serosanguineous pleural effusions in AIDS-associated Kaposi's sarcoma. Chest 1989; 96:460–6.
33. Bronnimann DA, Adam RD, Galgiani JN, et al. Coccidioidomycosis in the acquired immunodeficiency syndrome. Ann Intern Med 1987; 106:372–9.
34. Johnson PC, Khardori N, Najjar AF, Butt F, Mansell PWA, Sarosi GA. Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85:152–8.
35. Barnes PF, Verdegem TD, Vachon LA, Leedom JM, Overturf GD. Chest roentgenogram in pulmonary tuberculosis: new data on an old test. Chest 1988; 94:316–20.
36. Jules-Elysee KM, Stover DE, Zaman MB, Bernard EM, White DA. Aerosolized pentamidine: effect on diagnosis and presentation of Pneumocystis carinii pneumonia. Ann Intern Med 1990; 112:750–7.
37. Klein NC, Duncanson FP, Lenox TH III, Pitta A, Cohen SC, Wormser GP. Use of mycobacterial smears in the diagnosis of pulmonary tuberculosis in AIDS/ARC patients. Chest 1989; 95:1190–2.
38. So SY, Lam WK, Yu DYC. Rapid diagnosis of suspected pulmonary tuberculosis by fiberoptic bronchoscopy. Tubercle 1982; 63:195–200.
39. Bishburg E, Sunderam G, Reichman LB, Kapila R. Central nervous system tuberculosis with the acquired immunodeficiency syndrome and its related complex. Ann Intern Med 1986; 105:210–3.
40. Hewlett D Jr, Duncanson FP, Jagadha V, Lieberman J, Lenox TH, Wormser GP. Lymphadenopathy in an inner-city population consisting principally of intravenous drug abusers with suspected acquired immunodeficiency syndrome. Am Rev Respir Dis 1988; 137:1275–9.
41. Flora GS, Modilevsky T, Antoniskis D, Barnes PF. Undiagnosed tuberculosis in patients with human immunodeficiency virus infection. Chest 1990; 98:1056–9.
42. Damsker B, Bottone EJ. Mycobacterium avium-Mycobacterium intracellulare from the intestinal tracts of patients with the acquired immunodeficiency syndrome: concepts regarding acquisition and pathogenesis. J Infect Dis 1985; 151:179–81.
43. Young LS. Mycobacterium avium complex infection. J Infect Dis 1988; 157:863–7.
44. Davidson PT. Drug resistance and the selection of therapy for tuberculosis. Am Rev Respir Dis 1987; 136:255–7.
45. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1986; 134:355–63.
46. Small PM, Schecter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med 1991; 324:289–94.
47. Chaisson RE, Hopewell PC. Survival after active tuberculosis in patients with HIV infection. Am Rev Respir Dis 1990; 142: 259.
48. Walker AT, O'Brien RJ. Retrospective survey of treatment of tuberculosis in persons with AIDS. Am Rev Respir Dis 1990; 141: Suppl: A268. abstract.
49. Kavesh NG, Holzman RS, Seidlin M. The combined toxicity of azidothymidine and antimycobacterial agents: a retrospective study. Am Rev Respir Dis 1989; 139:1094–7.
50. Engelhard D, Stutman HR, Marks MI. Interaction of ketoconazole with rifampin and isoniazid. N Engl J Med 1984; 311:1681–3.
51. Lazar JD, Wilner KD. Drug interactions with fluconazole. Rev Infect Dis 1990; 12: Suppl 3: S327–S333.
52. Manoff SB, Cauthen GM, Stoneburner RL, et al. Tuberculosis patients with AIDS: are they more likely to spread tuberculosis? In: Proceedings of the Fourth International Conference on AIDS, Book two, Stockholm, Sweden, June 12–16, 1988. Stockholm: Swedish Ministry of Health and Social Affairs, 1988:260. abstract.
53. Mycobacterium tuberculosis transmission in a health clinic — Florida, 1988. MMWR 1989; 38:256–64.
54. Pitchenik AE, Burr J, Laufer M, et al. Outbreaks of drug-resistant tuberculosis at AIDS centre. Lancet 1990; 336:440–1.
55. Nosocomial transmission of multidrug-resistant tuberculosis to health care workers and HIV-infected patients in an urban hospital — Florida. MMWR 1990; 39:718–22.
56. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR 1990; 39: RR-17:1–29.
57. Nardell EA. Dodging droplet nuclei: reducing the probability of nosocomial tuberculosis transmission in the AIDS era. Am Rev Respir Dis 1990; 142:501–3.
58. Screening for tuberculosis and tuberculous infection in high-risk populations and the use of preventive therapy for tuberculous infection in the United States: recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR 1990; 39: RR-8:1–12.
59. Torres RA, Mani S, Altholz J, Brickner PW. Human immunodeficiency virus infection among homeless men in a New York City shelter: association with Mycobacterium tuberculosis infection. Arch Intern Med 1990; 150:2030–6.
60. International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ 1982; 60:555–64.